Do you obtain mycophenolate levels before escalating therapy in patients with extrarenal SLE?

I do not check them routinely unless I am concerned about compliance or potential side effects. It is reasonable to do so now that checking levels is readily available. It is not routine for lupus, as it is for transplant patients. In searching the literature, there is no controlled trial in lupus r...

Similar to Dr. @Dr. First Last, I primarily check MPA levels to assess adherence to therapy. Not surprisingly, poor adherence is common due to the high pill burden of taking mycophenolic acid analogs (MPAA). Finding an unexpectedly low level can open that conversation about identifying barriers and ...